Results for tag: "Lymphatic Malformations Drug"

Lymphatic malformations are a group of rare, congenital disorders that affect the lymphatic system. They are characterized by the abnormal development of lymphatic vessels, resulting in the accumulation of lymphatic fluid in the body. Treatment of lymphatic malformations typically involves the use of drugs that target the underlying cause of the disorder. These drugs are known as lymphoma drugs. Lymphoma drugs are used to reduce the size of lymphatic malformations, reduce the risk of infection, and improve the patient's quality of life. Commonly used lymphoma drugs include corticosteroids, interferon-alpha, and monoclonal antibodies. These drugs are typically administered intravenously or orally. The lymphatic malformations drug market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, and Roche. Other companies in the market include AbbVie, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more